ARTBIO secures $90m to advance alpha radioligand therapies pipeline
The funding will be used to solidify the firm’s AlphaDirect technology, which is a Pb212 isolation method, and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Dec 23
The funding will be used to solidify the firm’s AlphaDirect technology, which is a Pb212 isolation method, and…
06 Dec 23
Under the terms of this arrangement, the French pharmatech firm will use its deep physics and generative AI…
06 Dec 23
Financing led by Ascenta Capital with participation from new and existing investors; Dr. Lorence Kim joins board of…
05 Dec 23
The partnership combines AstraZeneca's expertise in oncology R&D with Absci's Integrated Drug Creation platform to expedite the discovery…
05 Dec 23
The proceeds from the funding round will be used by the company to advance the Phase 1 proof-of-mechanism…
29 Nov 23
AWS will help Amgen discover, develop, and boost the production throughput of medicines and increase sustainability and operational…
29 Nov 23
Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics technology
28 Nov 23
Under the partnership, Boehringer will leverage an AI model developed by IBM, initially pre-trained and subsequently fine-tuned using…
28 Nov 23
CEO Frederic Revah discusses how Artificial Intelligence is creating next-generation gene therapy vectors and reducing bioproduction costs in…
23 Nov 23
The company has designed an AI stack to detect new therapeutic targets and forecast responses of patients to…